Keywords: FORMA Therapeutics, Boehringer Ingelheim, R&D collaboration, Oncology targets

FORMA Thera in up to $815 million deal with Boehringer

Article | 06 January 2012

Print This

Fast-growing US drug discovery firm FORMA Therapeutics has entered into an R&D collaboration with family-owned German drugmaker Boehringer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in